Natera (NTRA Quick QuoteNTRA - Free Report) reported $546.6 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 32.2%. EPS of -$0.74 for the same period compares to -$0.30 a year ago.

The reported revenue represents a surprise of +15.66% over the Zacks Consensus Estimate of $472.59 million. With the consensus EPS estimate being -$0.60, the EPS surprise was -23.33%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Tests Processed Volume: 853,100 compared to the 826,455 average estimate based on three analysts.
• Revenues- Product: $544.43 million versus $466.57 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +32.4% change.
• Revenues- Licensing and other: $2.17 million versus the four-analyst average estimate of $2.24 million. The reported number represents a year-over-year change of +9.4%.

View all Key Company Metrics for Natera here>>>

Shares of Natera have returned -14.6% over the past month versus the Zacks S&P 500 composite's +1.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.